Safety, Tolerability, and Pharmacokinetics of Oral FB-101 in Healthy Subjects

NCT04165837 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: FB-101
DRUG: Placebo

Sponsor

1ST Biotherapeutics, Inc.